German lab CureVac announced this Tuesday (5) that it is suing rival BioNTech, which together with the drug Pfizer creates one of the main vaccines against covid, for infringement of intellectual property in its use of messenger RNA technology.
According to a company memo, CureVac stated that it had filed a lawsuit in the Düsseldorf district court “against BioNTech and its two affiliates, seeking fair compensation for infringement of intellectual property rights.”
The biotech company, known for its research on drugs using the messenger ribonucleic acid, wants to defend its rights arising from “twenty years of pioneering work in RNA technology that has contributed to the rapid development of vaccines against COVID.”
At a time of rising covid cases in several countries, CureVac has made sure that BioNTech and its partner do not want their “act of justice to interfere with their manufacture, sale or distribution” of their vaccines.
But the company estimates that its “22 years” of work on RNA technology, which allows for “rapid development” of vaccines against the new coronavirus, deserves a “fair pay” that is not specified by the lab.
source: Noticias
[author_name]
